Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 406 M397 M405 M425 M359 M371 M 1.56 B Research & development —————— — Operating income 184 M204 M206 M244 M18 M163 M 631 M Non-Operating Income, Total 32 M4 M5 M-21 M8 M-5 M -13 M Interest expense, net of interest capitalized 77 M86 M92 M86 M77 M63 M 318 M Non-Operating Income, excl. Interest Expenses 32 M4 M-87 M-107 M-69 M-68 M -331 M Unusual income/expense —————— — Pretax income 139 M121 M120 M136 M-51 M96 M 301 M Equity in earnings -17 M-18 M-11 M12 M-17 M-5 M -21 M Taxes 43 M29 M33 M37 M14 M3 M 87 M Non-controlling/minority interest 7 M9 M3 M4 M00 7 M After tax other income/expense —————— — Net income before discontinued operations 71 M65 M73 M109 M-82 M88 M 188 M Discontinued operations —————— — Net income 71 M65 M73 M109 M-82 M88 M 188 M Dilution adjustment ————1 M0 — Preferred dividends 0———4 M13 M — Diluted net income available to common stockholders 71 M65 M73 M109 M-85 M75 M 172 M Basic earnings per share (Basic EPS) 1.291.171.31.92-1.431.15 2.94 Diluted earnings per share (Diluted EPS) 1.281.171.291.92-1.431.15 2.93 Average basic shares outstanding 55.6 M55.9 M56.1 M56 M59.6 M65 M — Diluted shares outstanding 55.8 M56.1 M56.5 M56.2 M59.6 M65.2 M — EBITDA 190 M211 M210 M331 M55 M196 M 792 M EBIT 107 M131 M127 M239 M-44 M112 M 434 M Cost of revenue 3.01 B3.16 B3.44 B3.52 B2.86 B3.08 B 12.89 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 83 M80 M83 M92 M99 M84 M 358 M